Bryn Mawr Trust CO Charles River Laboratories International, Inc. Transaction History
Bryn Mawr Trust CO
- $4.09 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 96 shares of CRL stock, worth $16,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96
Previous 299
67.89%
Holding current value
$16,109
Previous $46,000
67.39%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
644Shares Held
51.7MCall Options Held
201KPut Options Held
179K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...